Avastin fakes in China were not contaminated, investigation continues

It turns out the counterfeit Avastin given off-label to Chinese patients was not contaminated as originally believed. Roche and health authorities found no microbial contamination in the fakes or the active ingredient. Researchers are now seeking a noninfectious cause for the inflammation. The 11 people who pleaded guilty in the counterfeiting case were awaiting sentencing as of May. Story

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.